(ENTA) Enanta Pharmaceuticals - Performance -57.9% in 12m
ENTA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-84.44%
#151 in Peer-Group
Rel. Strength
7.38%
#7119 in Stock-Universe
Total Return 12m
-57.92%
#143 in Peer-Group
Total Return 5y
-86.78%
#104 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 16.54 USD |
| 52 Week Low | 4.26 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 43.46 |
| Buy/Sell Signal +-5 | 2.13 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ENTA (-57.9%) vs XBI (-11.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.14% | 63.4% | 78.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
3.16% | -9.04% | 157% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.5% | -7.13% | 36% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
8.1% | -8.36% | 1.32% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-0.99% | 26.5% | -5.28% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
8.81% | 38.5% | -10.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.65% | 49.3% | -10.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.76% | 27.6% | 14.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ENTA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ENTA
| Total Return (including Dividends) | ENTA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -4.40% | 5.89% | 3.98% |
| 3 Months | 41.18% | 15.34% | 16.24% |
| 12 Months | -57.92% | -11.61% | 12.66% |
| 5 Years | -86.78% | -23.80% | 109.18% |
| Trend Score (consistency of price movement) | ENTA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -1.9% | 65.7% | 91.4% |
| 3 Months | 84.8% | 79.4% | 97.5% |
| 12 Months | -73.5% | -87.3% | 46.7% |
| 5 Years | -79.7% | -51.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th24.50 | -9.71% | -8.06% |
| 3 Month | %th70.50 | 22.41% | 21.45% |
| 12 Month | %th29.00 | -52.39% | -62.65% |
| 5 Years | %th47.50 | -82.66% | -93.68% |
FAQs
Does Enanta Pharmaceuticals (ENTA) outperform the market?
No,
over the last 12 months ENTA made -57.92%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.61%.
Over the last 3 months ENTA made 41.18%, while XBI made 15.34%.
Performance Comparison ENTA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ENTA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -9.7% | -8.4% | 35.8% | -71% |
| US NASDAQ 100 | QQQ | -9.8% | -8.6% | 33.4% | -71% |
| German DAX 40 | DAX | -9.4% | -6.4% | 25.2% | -87% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -11.2% | -9.6% | 33.9% | -78% |
| Hongkong Hang Seng | HSI | -10.5% | -7% | 14.5% | -92% |
| India NIFTY 50 | INDA | -8.2% | -5.1% | 36% | -55% |
| Brasil Bovespa | EWZ | -4.5% | -0.9% | 22.7% | -58% |
ENTA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -9.1% | -7.3% | 31.1% | -83% |
| Consumer Discretionary | XLY | -10.8% | -8.5% | 43% | -75% |
| Consumer Staples | XLP | -7.5% | -4.7% | 36.8% | -66% |
| Energy | XLE | -11.3% | -5.6% | 45.6% | -57% |
| Financial | XLF | -8.8% | -8.8% | 34.1% | -82% |
| Health Care | XLV | -9.5% | -4.4% | 46.5% | -51% |
| Industrial | XLI | -10.4% | -9.9% | 30.8% | -80% |
| Materials | XLB | -9.6% | -8.2% | 37.2% | -61% |
| Real Estate | XLRE | -9.9% | -5.1% | 37.6% | -66% |
| Technology | XLK | -9.3% | -9.8% | 31.2% | -68% |
| Utilities | XLU | -10% | -7.3% | 32.9% | -80% |
| Aerospace & Defense | XAR | -12.1% | -14.3% | 15.3% | -108% |
| Biotech | XBI | -14.6% | -10.3% | 41.9% | -46% |
| Homebuilder | XHB | -11.8% | -13.7% | 46.1% | -54% |
| Retail | XRT | -10.1% | -9.5% | 39.1% | -65% |
ENTA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -7.9% | -0.62% | 51.2% | -52% |
| Natural Gas | UNG | -10.2% | 5.6% | 61% | -64% |
| Gold | GLD | -9.2% | -3.2% | 19.1% | -96% |
| Silver | SLV | -12.6% | -9.2% | 16.5% | -81% |
| Copper | CPER | -19.1% | -17.9% | 18% | -80% |
ENTA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -8.4% | -5% | 41.3% | -54% |
| iShares High Yield Corp. Bond | HYG | -9% | -5.6% | 39% | -67% |